Article No
D087-3
Anti-GPI-80 (Human) mAb
Anti-GPI-80 (Human) mAb
Antibodies Primary
Specifications
| Application | FC, WB |
| Article No | D087-3 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
| Clone | 3H9 |
| Clone Type | monoclonal |
| Concentration | 1 mg/mL |
| Conjugation | Unconjugated |
| Description | Anti-GPI-80 (Human) mAb |
| Supplier | MBL |
| Immunogen | Human neutrophils activated with PMA |
| Isotype | IgG1 |
| Notes | The GPI-80 molecule (80 kDa) recognized by this antibody (clone 3H9) was shown to be present on human neutrophils. When 3H9 was added with a neutrophil stimulant (fMLP), the inhibition of neutrophil adherence was observed after 60 minutes incubation. 3H9 enhanced not only fMLP-induced chemotaxis but random migration of neutrophil as well. Furthermore, 3H9 clearly discriminated neutrophils from both basophils and eosinophils derived from humans. |
| Product Type | Antibodies Primary |
| Shipping Information | 4°C |
| Size | 100 µg |
| Source / Host | mouse |
| Species Reactivity | human |
| Stability | 1 year |
| Storage | -20°C |
| Substrate / Buffer | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained. |
| Technical Specifications | The GPI-80 molecule (80 kDa) recognized by this antibody (clone 3H9) was shown to be present on human neutrophils. When 3H9 was added with a neutrophil stimulant (fMLP), the inhibition of neutrophil adherence was observed after 60 minutes incubation. 3H9 enhanced not only fMLP-induced chemotaxis but random migration of neutrophil as well. Furthermore, 3H9 clearly discriminated neutrophils from both basophils and eosinophils derived from humans. |
| Product Page Updated | 2023-12-29T16:20:16.638Z |
